HESTER PHARM Fact Sheet, HESTER PHARM Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HESTER PHARM Fact Sheet    (HSPH)


REVEALED: 3 "Super Smallcaps" You Didn't Know About


Here is the latest financial fact sheet of HESTER PHARM. For more details, see the HESTER PHARM quarterly results and HESTER PHARM share price and chart. For a sector overview, read our pharmaceuticals sector report.

HESTER BIOSCIENCES Price History

Price Rs 2,502.3
Mkt Cap Rs m 21,286
Vol '000 3.7
P/E X 52.3
P/CF X 44.3
EPS (TTM) Rs 47.8
% ch % -0.9
No. of shares m 8.51
% ch week % -2.4
% ch 1-mth % 2.1
% ch 12-mth % 51.2
52 week H/L Rs 3,180.0/1,600.0
(As on Sep 20, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

HESTER BIOSCIENCES Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
HESTER BIOSCIENCES EQUITY SHARE DATA
High Rs8251,9501,8252,0442,278 
Low Rs4907711,040870934 
Sales per share (Unadj.) Rs142.0159.2209.2215.4251.9 
Earnings per share (Unadj.) Rs26.827.147.836.440.8 
Diluted earnings per shareRs26.827.147.836.440.8 
Cash flow per share (Unadj.) Rs35.038.561.651.856.4 
Dividends per share (Unadj.) Rs5.3010.0011.006.6010.00 
Adj. dividends per shareRs5.3010.0011.006.6010.00 
Avg Dividend yield %0.80.70.80.50.6 
Book value per share (Unadj.) Rs143.3165.3208.5236.3268.3 
Adj. book value per shareRs143.3165.3208.6236.4268.4 
Shares outstanding (eoy) m8.518.518.518.518.51 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x4.68.56.86.86.4 
Avg P/E ratio x24.550.229.940.039.4 
P/CF ratio (eoy) x18.835.423.228.128.5 
Price / Book Value ratio x4.68.26.96.26.0 
Dividend payout %19.836.923.018.124.5 
Avg Mkt Cap Rs m5,59411,57312,18612,39613,661 
No. of employees `000NANANANANA 
Total wages/salary Rs m183232289407389 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
HESTER BIOSCIENCES INCOME DATA
Net Sales Rs m1,2081,3551,7811,8332,143 
Other income Rs m426726447 
Total revenues Rs m1,2121,3801,8531,8962,190 
Gross profit Rs m410473680554653 
Depreciation Rs m7097118131133 
Interest Rs m3540667466 
Profit before tax Rs m309361569413501 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m81131162103154 
Profit after tax Rs m228231407310347 
Gross profit margin %33.934.938.230.230.5 
Effective tax rate %26.336.128.425.030.7 
Net profit margin %18.917.022.916.916.2 
HESTER BIOSCIENCES BALANCE SHEET DATA
Current assets Rs m8009841,4171,5931,615 
Current liabilities Rs m380546487835614 
Net working cap to sales %34.732.352.241.446.7 
Current ratio x2.11.82.91.92.6 
Inventory Days Days2710122113 
Debtors Days Days80876711684 
Net fixed assets Rs m1,3291,4561,5782,2732,495 
Share capital Rs m8585858585 
"Free" reserves Rs m1,1341,3211,6901,9262,198 
Net worth Rs m1,2191,4061,7752,0112,283 
Long term debt Rs m446365584765828 
Total assets Rs m2,1292,4402,9953,8664,110 
Interest coverage x9.89.99.66.68.6 
Debt to equity ratio x0.40.30.30.40.4 
Sales to assets ratio x0.60.60.60.50.5 
Return on assets %12.311.115.89.910.0 
Return on equity %18.716.422.915.415.2 
Return on capital %20.722.726.917.518.2 
Exports to sales %11.18.36.711.016.6 
Imports to sales %2.71.22.50.60 
Exports (fob) Rs m135113120202357 
Imports (cif) Rs m331645120 
Fx inflow Rs m156135128366357 
Fx outflow Rs m6830744221 
Net fx Rs m8710554324336 
HESTER BIOSCIENCES CASH FLOW
From Operations Rs m 348 380 467 368 581 
From Investments Rs m -302 -258 -217 -745 -384 
From Financial Activity Rs m 18 -111 27 187 -182 
Net Cashflow Rs m 64 11 283 -171 -23 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 53.7%
Institution 1.0%
Non-Institution 45.3%
Total 100.0%
Free Float 46.3%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF Pushpak’ 1st Floor, Panchvati Circle, Motila Hirabhai Road, Ahmedabad - 380006
E-MAIL mail@hester.in WEB www.hester.in
TEL 079 – 26445107 FAX 079 – 26445105
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Link Intime India Pvt Ltd., 506-508 5th Floor Amaranth Business Complex - I (ABC - I), Beside Gala Business Center St. Xaviers Corner Off C.G. Road, Navrangpura
YEAR OF INC: 1987 BSE CODE: 524669 FV (Rs): 10 DIV YIELD (%): 0.4

More Pharmaceuticals Company Fact Sheets:   GLENMARK PHARMA  DIVIS LABORATORIES  ALKEM LABORATORIES  JENBURKT PH.  DISHMAN CARBOGEN AMCIS  

Compare HESTER BIOSCIENCES With:   GLENMARK PHARMA  DIVIS LABORATORIES  ALKEM LABORATORIES  JENBURKT PH.  DISHMAN CARBOGEN AMCIS  




Today's Market

5 Reasons Why Sensex Plunged 525 Points Today(Closing)

It was indeed a volatile day for Indian share markets today. Tracking a rout in the global markets, benchmark indices tumbled for the second day.

Views on news

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Cipla Shares Tank Despite Strong Earnings (Views On News)

Aug 6, 2021

The stock fell 3.5% even as the company reported numbers higher than analysts' expectations.

Glenmark Life Sciences Makes Lacklustre Debut. Shares List At 4% Premium (Views On News)

Aug 6, 2021

Glenmark Life Sciences' IPO had received strong response from investors as the offer was subscribed 44.17 times.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider (Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore (Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

5 Indian Companies that are Leading the AI Race (Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

The Top Stocks to Sell in this Bull Market (Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year (Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK HESTER BIOSCIENCES

  • Track your investment in HESTER BIOSCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON HESTER BIOSCIENCES

HESTER BIOSCIENCES - RAYMED LABS COMPARISON

COMPARE HESTER BIOSCIENCES WITH

MARKET STATS